Latest Articles

Publication Date
All News Scientific
Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis.

[This corrects the article DOI: 10.3389/fimmu.2021.641206.].

Published: Nov. 24, 2025, midnight
Read Full Article
Sunitinib endometriosis gene expressions immunosuppression myeloid-derived suppressor cells
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!